Polygeline

also known as Poligelina

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 3	NCT02686151 Background	Dec 2023 → Mar 2024	ovarian hyperstimulation syndrome	The Affiliated Hospital of Inner Mongolia Medical University	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Polygeline	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02686151 ↗
Known as	Poligelina	ChEMBL registry synonym — accepted as the source's own label CHEMBL2108135 ↗
Modality	Small molecule	— CHEMBL2108135 ↗
Route	Intravenous	“intravenous injection” NCT02686151 ↗